Zimmer Biomet Holdings, Inc. announced the appointment of Paul Stellato as Vice President, Controller and Chief Accounting Officer. Prior to joining Zimmer Biomet, Mr. Stellato served as Vice President, Finance, Global Business Services at Xylem Inc. Prior to his most recent role at Xylem Inc., Mr. Stellato served as the company's Vice President, Controller and Chief Accounting Officer and as Vice President Finance, Financial Planning and Analysis.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
115.2 USD | +0.62% | -1.08% | -5.38% |
05-31 | Zimmer Biomet's Limited Exposure to High-Growth Markets Spurs Revenue Concerns, UBS Says | MT |
05-31 | Barclays Adjusts Price Target on Zimmer Biomet to $125 From $130 | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-5.38% | 23.69B | |
-7.16% | 178B | |
-1.23% | 107B | |
-4.86% | 67.04B | |
-4.28% | 47.24B | |
+10.32% | 44.62B | |
+8.14% | 42.5B | |
+15.76% | 29.99B | |
+15.53% | 25.22B | |
-5.88% | 24.14B |
- Stock Market
- Equities
- ZBH Stock
- News Zimmer Biomet Holdings, Inc.
- Zimmer Biomet Holdings, Inc. Appoints Paul Stellato as Controller and Chief Accounting Officer